Vineet Laboratories Limited (NSE:VINEETLAB)

Market Cap	312.62M
Revenue (ttm)	584.49M -48.5%
Net Income	-166.97M
EPS	-18.04
Shares Out	9.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,927
Average Volume	82,283
Open	34.91
Previous Close	33.91
Day's Range	32.25 - 34.91
52-Week Range	26.51 - 55.69
Beta	-0.08
RSI	41.12
Earnings Date	Jan 22, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th...

• Industry: Chemicals
• Sector: Materials
• Founded: 2016
• Employees: 57
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VINEETLAB